News

BioM's articles and press releases about the Bavarian biotechnology sector


Swiss Biotech Day 2025: Visit us at the BioM booth and take part in the Swiss-Bavarian Roundtable and the Marketplace Reception!

The Swiss Bi­otech Day will again take place from 05 to 06 May 2025 in Basel (Switzer­land). The SBD has be­come one of the key events in…

LSX World Congress 2025: Meet us at the Bavarian Booth #13!

The LSX World Con­gress will take place from 29 - 30 April 2025 in Lon­don, UK. A dy­nam­ic forum that brings to­geth­er life sci­ence and…

Cross-faculty Expert Talk: From the idea to a start-up - practical tips – challenges – success factors

From the idea to a start-up - prac­tic­al tips – chal­lenges – suc­cess factors will be the topic of the Cross-fac­ulty Ex­pert Talk - an…

BIO-Japan 2025: Register now for the Bavarian Booth!

From 8 - 10 Octo­ber 2025, BIO-Japan will take place in Yoko­hama (Japan). For the second largest phar­ma­ceut­ic­al mar­ket in the world,…

Meliodays Medical secures EUR 800,000 for hormone-free treatment of menstrual pain

The Mu­nich-based start-up Meli­odays Med­ic­al has suc­cess­fully closed an over­sub­scribed pre-seed fin­an­cing round, rais­ing over EUR…

Researchers from Bayreuth create hyrdogel that can self-heal like human skin

A re­search team from the Universität Bayreuth and Aalto University in Fin­land has, for the first time, suc­ceeded in de­vel­op­ing a…

TUM Scientists develop a gentle, efficient method to purify proteins with light

Scient­ists at the Tech­nic­al University of Mu­nich (TUM) have de­veloped a meth­od that re­lies on phys­ics rather than con­ven­tion­al…

Erlangen University Hospital receives 600,000 US dollars in funding for translational study on CAR T-cell therapy for lupus erythematosus

More than 45 people with autoim­mune dis­eases have been suc­cess­fully treated with a novel CAR-T cell ther­apy at the University…

Formycon launches FYB202/Otulfi®, a biosimilar to Stelara®, in the United States and the European Union

For­my­con AG and its com­mer­cial­iz­a­tion part­ner Freseni­us an­nounce the com­mer­cial avail­ab­il­ity of Otulfi®1, a bi­osim­il­ar…

Newsletter

Subscribe

Archive



Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager